Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

被引：0
|
作者：
Simon Kind
Franziska Büscheck
Doris Höflmayer
Claudia Hube-Magg
Martina Kluth
Maria Christina Tsourlakis
Stefan Steurer
Till S. Clauditz
Andreas M. Luebke
Eike Burandt
Waldemar Wilczak
Andrea Hinsch
David Dum
Sören Weidemann
Christoph Fraune
Burkhard Beyer
Thomas Steuber
Hartwig Huland
Markus Graefen
Margit Fisch
Ronald Simon
Guido Sauter
Thorsten Schlomm
Sarah Minner
Till Eichenauer
机构：
[1] University Medical Center Hamburg-Eppendorf,Institute of Pathology
[2] University Medical Center Hamburg-Eppendorf,Department of Urology
[3] University Medical Center Hamburg-Eppendorf,Martini
[4] Universitätsmedizin Berlin,Clinic, Prostate Cancer Center
来源：
World Journal of Urology | 2020年 / 38卷
关键词：
Prostate cancer; Prognosis; Claudin-1; Immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2185 / 2196
页数：11
相关论文
共 50 条
  • [1] Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
    Kind, Simon
    Buescheck, Franziska
    Hoeflmayer, Doris
    Hube-Magg, Claudia
    Kluth, Martina
    Tsourlakis, Maria Christina
    Steurer, Stefan
    Clauditz, Till S.
    Luebke, Andreas M.
    Burandt, Eike
    Wilczak, Waldemar
    Hinsch, Andrea
    Dum, David
    Weidemann, Soeren
    Fraune, Christoph
    Beyer, Burkhard
    Steuber, Thomas
    Huland, Hartwig
    Graefen, Markus
    Fisch, Margit
    Simon, Ronald
    Sauter, Guido
    Schlomm, Thorsten
    Minner, Sarah
    Eichenauer, Till
    WORLD JOURNAL OF UROLOGY, 2020, 38 (09) : 2185 - 2196
  • [2] PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
    Marie-Christine Heinrich
    Cosima Göbel
    Martina Kluth
    Christian Bernreuther
    Charlotte Sauer
    Cornelia Schroeder
    Christina Möller-Koop
    Claudia Hube-Magg
    Patrick Lebok
    Eike Burandt
    Guido Sauter
    Ronald Simon
    Hartwig Huland
    Markus Graefen
    Hans Heinzer
    Thorsten Schlomm
    Asmus Heumann
    BMC Cancer, 18
  • [3] PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
    Heinrich, Marie-Christine
    Goebel, Cosima
    Kluth, Martina
    Bernreuther, Christian
    Sauer, Charlotte
    Schroeder, Cornelia
    Moeller-Koop, Christina
    Hube-Magg, Claudia
    Lebok, Patrick
    Burandt, Eike
    Sauter, Guido
    Simon, Ronald
    Huland, Hartwig
    Graefen, Markus
    Heinzer, Hans
    Schlomm, Thorsten
    Heumann, Asmus
    BMC CANCER, 2018, 18
  • [4] Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
    Leinonen, Katri A.
    Saramaki, Outi R.
    Furusato, Bungo
    Kimura, Takahiro
    Takahashi, Hiroyuki
    Egawa, Shin
    Suzuki, Hiroyoshi
    Keiger, Kerri
    Hahm, Sung Ho
    Isaacs, William B.
    Tolonen, Teemu T.
    Stenman, Ulf-Hakan
    Tammela, Teuvo L. J.
    Nykter, Matti
    Bova, G. Steven
    Visakorpi, Tapio
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (12) : 2333 - 2344
  • [5] Characterizing the Molecular Features of ERG-Positive Tumors in Primary and Castration Resistant Prostate Cancer
    Roudier, Martine P.
    Winters, Brian R.
    Coleman, Ilsa
    Lam, Hung-Ming
    Zhang, Xiaotun
    Coleman, Roger
    Chery, Lisly
    True, Lawrence D.
    Higano, Celestia S.
    Montgomery, Bruce
    Lange, Paul H.
    Snyder, Linda A.
    Srivastava, Shiv
    Corey, Eva
    Vessella, Robert L.
    Nelson, Peter S.
    Uren, Aykut
    Morrissey, Colm
    PROSTATE, 2016, 76 (09): : 810 - 822
  • [6] ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
    Furusato, B.
    Tan, S-H
    Young, D.
    Dobi, A.
    Sun, C.
    Mohamed, A. A.
    Thangapazham, R.
    Chen, Y.
    McMaster, G.
    Sreenath, T.
    Petrovics, G.
    McLeod, D. G.
    Srivastava, S.
    Sesterhenn, I. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (03) : 228 - 237
  • [7] ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
    B Furusato
    S-H Tan
    D Young
    A Dobi
    C Sun
    A A Mohamed
    R Thangapazham
    Y Chen
    G McMaster
    T Sreenath
    G Petrovics
    D G McLeod
    S Srivastava
    I A Sesterhenn
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 228 - 237
  • [8] Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
    Burdelski, Christoph
    Bujupi, Erzen
    Tsourlakis, Maria Christina
    Hube-Magg, Claudia
    Kluth, Martina
    Melling, Nathaniel
    Lebok, Patrick
    Minner, Sarah
    Koop, Christina
    Graefen, Markus
    Heinzer, Hans
    Wittmer, Corinna
    Sauter, Guido
    Wilczak, Waldemar
    Simon, Ronald
    Schlomm, Thorsten
    Steurer, Stefan
    Krech, Till
    PLOS ONE, 2015, 10 (06):
  • [9] Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
    Kim, Sung Han
    Kim, Soo Hee
    Joung, Jae Young
    Lee, Geon Kook
    Hong, Eun Kyung
    Kang, Kyung Min
    Yu, Ami
    Nam, Byung Ho
    Chung, Jinsoo
    Seo, Ho Kyung
    Park, Weon Seo
    Lee, Kang Hyun
    PLOS ONE, 2015, 10 (04):
  • [10] Androgen Receptor CAG Repeat Polymorphism and Risk of TMPRSS2: ERG-Positive Prostate Cancer
    Yoo, Sun
    Pettersson, Andreas
    Jordahl, Kristina M.
    Lis, Rosina T.
    Lindstrom, Sara
    Meisner, Allison
    Nuttall, Elizabeth J.
    Stack, Edward C.
    Stampfer, Meir J.
    Kraft, Peter
    Brown, Myles
    Loda, Massimo
    Giovannucci, Edward L.
    Kantoff, Philip W.
    Mucci, Lorelei A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 2027 - 2031
12345